Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN358141 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Inhibitor of kappa Light Polypeptide Gene Enhancer in B-Cells, Kinase beta (IKBKB) (pTyr199) antibody
- Antibody type
- Polyclonal
- Description
- Protein G Affinity Chromatography. Then, the antibody fraction is peptide affinity purified in a 2-step procedure with control and phosphorylated peptides. The phospho-specific antibody is eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- pTyr199
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells.
Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro.
A novel ubiquitin-like domain in IkappaB kinase beta is required for functional activity of the kinase.
TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6.
Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta.
Tomasoni S, Aiello S, Cassis L, Noris M, Longaretti L, Cavinato RA, Azzollini N, Pezzotta A, Remuzzi G, Benigni A
Transplantation 2005 May 15;79(9):1056-61
Transplantation 2005 May 15;79(9):1056-61
Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro.
Lappas M, Yee K, Permezel M, Rice GE
Endocrinology 2005 Mar;146(3):1491-7
Endocrinology 2005 Mar;146(3):1491-7
A novel ubiquitin-like domain in IkappaB kinase beta is required for functional activity of the kinase.
May MJ, Larsen SE, Shim JH, Madge LA, Ghosh S
The Journal of biological chemistry 2004 Oct 29;279(44):45528-39
The Journal of biological chemistry 2004 Oct 29;279(44):45528-39
TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6.
Ea CK, Sun L, Inoue J, Chen ZJ
Proceedings of the National Academy of Sciences of the United States of America 2004 Oct 26;101(43):15318-23
Proceedings of the National Academy of Sciences of the United States of America 2004 Oct 26;101(43):15318-23
Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta.
Cárcamo JM, Pedraza A, Bórquez-Ojeda O, Zhang B, Sanchez R, Golde DW
Molecular and cellular biology 2004 Aug;24(15):6645-52
Molecular and cellular biology 2004 Aug;24(15):6645-52
No comments: Submit comment
No validations: Submit validation data